Binding probe circuits for molecular sensors

Patent metadata

Field	Value
Publication number	US-10648941-B2
Application number	US-201816015049-A
Country	US
Kind code	B2
Filing date	Jun 21, 2018
Priority date	May 9, 2017
Publication date	May 12, 2020
Grant date	May 12, 2020

Abstract

In various embodiments a molecular circuit is disclosed. The circuit comprises a negative electrode, a positive electrode spaced apart from the negative electrode, and a binding probe molecule conductively attached to both the positive and negative electrodes to form a circuit having a conduction pathway through the binding probe. In various examples, the binding probe is an antibody, the Fab domain of an antibody, a protein, a nucleic acid oligomer hybridization probe, or an aptamer. The circuit may further comprise molecular arms used to wire the binding probe to the electrodes. In various embodiments, the circuit functions as a sensor wherein electrical signals, such as changes to voltage, current, impedance, conductance, or resistance in the circuit, are measured as targets interact with the binding probe. In various embodiments, the circuit provides a means to measure the presence, absence, or concentration of an analyte in a solution.

First claim

We claim:

1. A circuit comprising:
a first electrode;
a second electrode spaced apart from the first electrode;
a binding probe electrically connected to the first electrode by a first arm molecule, and electrically connected to the second electrode by a second arm molecule, to form a conductive pathway between the first and second electrodes through the binding probe;
wherein each of the first and second arm molecules independently comprise a protein alpha-helix, a graphene nanoribbon, or an antibody Fab domain;
wherein each of the first and second arm molecules has a first end and a second end, wherein the first end of the first arm molecule is conjugated to the binding probe and the second end of the first arm molecule is bonded to the first electrode, wherein the first end of the second arm molecule is conjugated to the binding probe and the second end of the second arm molecule is bonded to the second electrode, and wherein the first end of each of the first and second arm molecules bond are conjugated to two distinct sites on the binding probe so that a portion of the binding probe is included in the conductive pathway.

2. The circuit of claim 1 , wherein the first electrode is a positive electrode and the second electrode is a negative electrode, or wherein the first electrode is a negative electrode and the second electrode is a positive electrode.

3. The circuit of claim 1 , wherein at least one of the first end of the first arm molecule or the first end of the second arm molecule is conjugated to an internal structural element of the binding probe.

4. The circuit of claim 3 , wherein the internal structural element is selected from the group consisting of an alpha-helix, a beta-sheet, and a multiple of such elements in series.

5. The circuit of claim 1 , wherein at least one of the first end of the first arm molecule or the first end of the second arm molecule is conjugated to the binding probe at a location of the binding probe capable of undergoing a conformational change.

6. The circuit of claim 1 , wherein the at least one of the first arm molecule or the second arm molecule comprises a molecule having tension, twist or torsion dependent conductivity.

7. The circuit of claim 1 , wherein the binding probe comprises an antibody Fab binding domain having a heavy chain and a light chain.

8. The circuit of claim 7 , wherein the circuit is usable to sense information on the presence of, or concentration of a corresponding antibody antigen in a test solution.

9. The circuit of claim 7 , wherein the two distinct sites on the binding probe consist of the ends of beta-sheets on the heavy and the light chains of the antibody Fab binding domain that are complexed together to provide part of an interaction that holds the heavy and light chains together.

10. The circuit of claim 1 , wherein the binding probe comprises an aptamer.

11. The circuit of claim 10 , wherein the circuit is usable to sense information on the presence of, or concentration of a target molecule of the aptamer in a test solution.

12. The circuit of claim 11 , wherein the circuit is usable to sense information on the presence of, or concentration of a target DNA or RNA molecule in a test solution.

13. The circuit of claim 1 , wherein the binding probe comprises an immunoglobulin protein.

14. The circuit of claim 13 , wherein the immunoglobulin protein is genetically modified.

15. The circuit of claim 1 , wherein the binding probe comprises a nucleic acid oligomer hybridization probe.

16. The circuit of claim 1 , wherein the binding probe is engineered to have additional charge groups.

17. The circuit of claim 1 , wherein at least one of the first end of the first arm molecule or the first end of the second arm molecule is conjugated to the binding probe at connection points in the binding probe comprising at least one of a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.

18. The circuit of claim 1 , further comprising a gate electrode.

19. A method of molecular detection, comprising:
providing the circuit of claim 18 ;
initiating at least one of a voltage or a current through the circuit;
exposing the circuit to at least one of: a buffer of reduced ionic strength, specific applied voltage on the first electrode and the second electrode, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the first electrode and the second electrode, or gate electrode; and
measuring an electrical change in the circuit.

20. The method of claim 19 , wherein the electrical change is processed to identify the presence of, or concentration of an antigen.

21. The method of claim 19 , wherein the electrical change in the circuit may be measured as targets interact with the binding probe.

22. The circuit of claim 1 , wherein the circuit resides on a sensor array electronic measurement chip with an array of sensor pixel electronic elements, said sensor pixel electronic elements monitor the electrical signal from a single binding probe molecular circuit.

23. The circuit of claim 22 , wherein the sensor array electronic measurement chip comprises a CMOS chip.

24. A method of detecting the concentration of an analyte in a solution, comprising:
providing the circuit of claim 1 , wherein the binding probe is capable of binding the analyte;
initiating at least one of a voltage or a current through the circuit;
exposing the circuit to the solution for a defined period of time; and
measuring electrical signals through the circuit as the binding probe engages with the analyte,
wherein the electrical signals are processed to identify features that provide information on the concentration of the analyte in the solution.

25. The method of claim 24 , wherein the concentration of the analyte in solution correlates to an overall rate of detection of the analyte to provide a qualitative measure of concentration.

26. The method of claim 25 , wherein the qualitative measure of concentration is calibrated to provide a quantitative measure of concentration of the analyte.

27. A method of performing a binding detection assay, comprising:
providing a binding probe-based molecular circuit having spaced-apart first and second electrodes and a binding probe molecule, wherein the binding probe is electrically connected to the first electrode by a first arm molecule, and electrically connected to the second electrode by a second arm molecule to form a conductive pathway between the first and second electrodes through the binding probe, wherein each of the first and second arm molecules independently comprise a protein alpha-helix, a graphene nanoribbon, or an antibody Fab domain, wherein each of the first and second arm molecules has a first end and a second end, wherein the first end of the first arm molecule is conjugated to the binding probe and the second end of the first arm molecule is bonded to the first electrode, wherein the first end of the second arm molecule is conjugated to the binding probe and the second end of the second arm molecule is bonded to the second electrode, and wherein the first end of each of the first and second arm molecules are conjugated to two distinct sites on the binding probe so that a portion of the binding probe is included in the con

Assignees

• Roswell Biotechnologies Inc

Inventors

• Merriman Barry L
• Govindaraj Venkatesh Alagarswamy
• Mola Paul
• Geiser Tim
• Costa Gina

Classifications

• G01N27/3275 Primary

  Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction · CPC title

• C12Q1/6825 Primary

  Nucleic acid detection involving sensors · CPC title

• G01N27/4145

  specially adapted for biomolecules, e.g. gate electrode with immobilised receptors · CPC title

• G01N33/5438 Primary

  Electrodes · CPC title

• G01N27/3276

  being a hybridisation with immobilised receptors (using a FET type sensor G01N27/4145; concerning the hybridisation C12Q1/68) · CPC title